Showing results (61-70 of 94) with videos related to
Sort By:
Pageof 10
ACS Nano|December 4, 2018
Integration of Polymerization and Biomineralization as a Strategy to Facilely Synthesize Nanotheranostic AgentsBing Xiao, Xiaoxuan Zhou, Hongxia Xu, et al.ACS Nano|June 1, 2026
Localized Depletion of Macrophages by Abdominal Cavity Retention Nanoparticles as a Potential Therapy for Peritoneal MetastasisRong Li, Yutao Qiu, Xiaoxian Duan, et al.Biomaterials|August 25, 2017
Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast-induced drug resistanceLiying Wang, Xiangrui Liu, Quan Zhou, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2016
Jumping the nuclear envelop barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306Xuefei Zhou, Xiangrui Liu, Bingxiang Zhao, et al.Medcomm|August 28, 2023
Nano-calcipotriol as a potent anti-hepatic fibrosis agentYina Zhang, Liying Wang, Jiajia Shao, et al.International Journal of Biological Macromolecules|April 20, 2026
Acetylation of GPRC5A at Lys348 facilitates cisplatin resistance and promotes the recurrence and poor prognosis in ovarian cancerQiangqiang He, Meiyu Qu, Yuanyuan Yang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 21, 2015
Amphiphilic drugs as surfactants to fabricate excipient-free stable nanodispersions of hydrophobic drugs for cancer chemotherapyShiqi Hu, Eunhye Lee, Chi Wang, et al.International Journal of Nanomedicine|March 1, 2022
Development of a Novel MR Colonography via Iron-Based Solid Lipid NanoparticlesHuiyang Wang, Siqi Wang, Xisong Zhu, et al.Cancer Biology & Medicine|August 4, 2021
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of <i>KRAS</i>-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 24, 2023
Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cellsShenglong Xia, Zimo Liu, Jieru Cai, et al.Pageof 10